Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
L-Methyl Folate IP (0.8 mg) Tablet
Therapeutic Category
Nutraceuticals, Multivitamins and Multiminerals, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹490/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Folyflit Tablet contains L-Methyl Folate, the active and bioavailable form of folic acid (Vitamin B9). Unlike synthetic folic acid, L-Methyl Folate does not require enzymatic conversion by methylenetetrahydrofolate reductase (MTHFR) and is directly available for cellular use. This makes it especially beneficial for individuals with MTHFR polymorphisms or impaired folate metabolism. L-Methyl Folate plays a crucial role in DNA synthesis, red blood cell production, homocysteine metabolism, and neurotransmitter synthesis. It is commonly used in the prevention and treatment of folate deficiency, megaloblastic anemia, and as a nutritional supplement in pregnancy to prevent neural tube defects. Additionally, it serves as an adjunct in cardiovascular health and certain psychiatric conditions linked to folate deficiency.
Folyflit is generally well tolerated. Mild side effects may include nausea, bloating, or gastrointestinal discomfort. Rarely, allergic reactions such as rash, itching, or swelling can occur. Very high doses may mask Vitamin B12 deficiency, so proper diagnosis is essential in megaloblastic anemia cases.
Folyflit Tablet is indicated for the prevention and treatment of folate deficiency, megaloblastic anemia, and as a prenatal supplement to prevent neural tube defects in developing fetuses. It is also used as adjunctive therapy in hyperhomocysteinemia, cardiovascular disorders, and in certain psychiatric conditions where folate metabolism support is beneficial.
Folyflit Tablet should be taken under medical guidance, especially in patients with anemia to confirm the underlying cause. It is safe for use during pregnancy and lactation at recommended doses. Individuals with Vitamin B12 deficiency should be supplemented accordingly to prevent neurological complications. Avoid self-medication in high doses without consulting a healthcare professional. Consistent use is necessary to achieve therapeutic benefits in deficiency states.
Store Folyflit Tablet in a cool, dry place below 30°C. Protect from direct sunlight and moisture. Keep the tablets in their original blister pack and out of reach of children. Do not use after the expiry date mentioned on the strip.
Composition : L-Methyl Folate (1mg) + Methylcobalamin (1500mcg) + Pyridoxal-5-phosphate (0.5mg) + Docosahexaenoic Acid (DHA) (200mg)
Composition : L-Methyl Folate (1mg) + Methylcobalamin (1500mcg) + Pyridoxal-5-phosphate (0.5mg)
Composition : Folic Acid (5mg) Tablet
Composition : Biotin (5mg) + Folic Acid (5mg)
Composition : Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered
Composition : Acebrophylline (200mg) + Desloratadine (5mg) + Montelukast (10mg) Tablet
Composition : Bilastine (20mg) Tablet
Composition : Bilastine (40mg) Tablet
Composition : Bilastine (20mg) + Montelukast (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
L-Methyl Folate I.P. 0.8mg Tablet has strong demand in the gynecology, prenatal care, hematology, and nutraceutical segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on women’s health and nutritional support portfolios.
Medical distributors and agencies can benefit from consistent demand for folate supplementation and nutritional support under healthcare professional guidance. L-Methyl Folate is the biologically active form of folic acid that is readily utilized by the body Supports red blood cell formation, cellular health, and nutritional well-being Commonly recommended during preconception care, pregnancy, and folate deficiency management as advised by healthcare professionals This strengthens a reliable gynecology and nutraceutical portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for L-Methyl Folate I.P. 0.8mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from gynecologist and physician recommendations, growing demand for prenatal nutrition products, repeat consumer usage, strong retail movement, reliable supply chain support, and good margins in nutraceutical products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing, product availability, and business terms, secure monopoly territory rights, and benefit from comprehensive marketing support, high-quality products, attractive profit margins, and a reliable supply chain to grow their pharmaceutical business successfully.